Skip to content

Therapeutic Endpoint in Pediatric IBD Conditions

Development of a Therapeutic Endpoint in Pediatric IBD Conditions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06065228
Enrollment
60
Registered
2023-10-03
Start date
2023-11-27
Completion date
2027-12-01
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Brief summary

The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.

Interventions

Physiologic characterization of disease activity

Sponsors

Children's National Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Male or female ≥ 6 years of age at screening. * Documentation of an IBD diagnosis as evidenced by history

Exclusion criteria

* Documented history of eye disease precluding pupillometry * Patients who are unwilling or unable to participate due to developmental delays or ongoing psychological diagnoses.

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is the measurement of the nociceptive index for clinical output.1 Year

Secondary

MeasureTime frame
The secondary objective of this study is the characterization of the nociceptive index in IBD populations in response to standard of care interventions.1 Year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026